Cigna Group, US1255231003

Cigna launches Health Sense: Piper targets Cigna Group stock at USD 370

Published on 10/15/2026 at 10:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Health Sense targets 10.00 percent less waste by 2030 after its October 6 launch. Cigna Group stock costs EUR 258.70, 0.50 percent below Xetra close.

Revenue and guidance shape the outlook

  • Health Sense targets 10.00 percent less inefficient spending by 2030 after its October 6, 2026 launch.
  • Second-quarter 2026 revenue reached USD 71.7 billion, while adjusted earnings per share came to USD 7.78.
  • Cigna Group stock trades at EUR 258.70 at 10:00 a.m. CEST at Lang & Schwarz on October 15, 2026, 0.50 percent below the Xetra close of October 14, 2026.
  • The Cigna Group will release third-quarter 2026 results on November 5, 2026.
Cigna Group Beratungsgespräch in Schwarzweiß-Reportage-Stil, ISIN US1255231003, Arzt und Patient im Büro, Illustration mit AI erstellt.

The Cigna Group (ISIN US1255231003) was trading at EUR 258.70 at Lang & Schwarz on October 15, 2026 at 10:00 a.m. CEST, 0.50 percent below the Xetra close of October 14, 2026 at EUR 260.00. The company launched Health Sense on October 6, a personalized care model projected to reduce inefficient healthcare spending by 10.00 percent by 2030, according to Yahoo Finance.

Health Sense adds a measurable target

The initiative initially targets oncology and cardiometabolic conditions and is planned to begin in early 2027. Its 10.00 percent spending goal gives the strategy a concrete operating benchmark rather than a broad technology promise.

The latest reported quarter provides the financial base for that initiative. In the second quarter of 2026, total revenue rose to USD 71.7 billion and adjusted earnings per share reached USD 7.78, according to Yahoo Finance. Revenue was 7.00 percent higher than a year earlier, while management raised full-year 2026 adjusted earnings per share guidance to at least USD 30.45.

What does the earnings base mean?

The second-quarter figures show where investors will look for proof that Health Sense can support the broader model. Specialty and Care Services delivered 22.00 percent year-over-year growth in pre-tax adjusted earnings to USD 1.1 billion, while Cigna Healthcare revenue grew 10.00 percent year over year to USD 11.8 billion.

Three dated steps in the strategy

The company reported second-quarter 2026 revenue of USD 71.7 billion on July 30, 2026, with adjusted earnings per share of USD 7.78, according to Yahoo Finance. At its September 30, 2026 Investor Day, The Cigna Group reaffirmed adjusted earnings per share guidance of at least USD 30.45 and set a 10.00 percent to 14.00 percent adjusted earnings per share growth target through 2030, according to PR Newswire. The Health Sense launch followed on October 6, 2026 with its 10.00 percent spending objective.

Next results arrive November 5

The next scheduled dates are November 5, 2026, for the release of third-quarter results, and November 5, 2026, for the earnings conference call. The release is planned by 6:30 a.m. ET and the call at 8:30 a.m. ET, according to Yahoo Finance.

Stock remains below the Xetra close

The euro quotation was EUR 1.30 below the Xetra close on October 14, 2026. The primary listing is on the NYSE under ticker CI, while the current German-market indication places the stock 0.50 percent below that reference level.

The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.

Cigna Group market facts

  • Company: The Cigna Group
  • ISIN: US1255231003
  • Ticker: CI
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 15, 2026, 10:00 a.m. CEST): EUR 258.70
  • Change versus Xetra close: minus 0.50 percent
  • Xetra close (October 14, 2026): EUR 260.00
  • Market capitalization: USD 67.9 billion (as of October 15, 2026)
  • 52-week range: EUR 208.40-EUR 270.20 (as of October 15, 2026)
  • Sector / Industry: Healthcare / Medical - Healthcare Plans
  • Next earnings date: November 5, 2026

Market context: Market report S&P 500.

More news and analyses on Cigna Group stock

Disclaimer...
en | US1255231003 | CIGNA GROUP | boerse | 70326706 | bgmi